Marshall Wace, LLP Vincerx Pharma, Inc. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 328,533 shares of VINC stock, worth $233,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
328,533
Previous 71,566
359.06%
Holding current value
$233,258
Previous $362,000
26.52%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VINC
# of Institutions
29Shares Held
10.7MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX2.49MShares$1.77 Million0.63% of portfolio
-
Armistice Capital, LLC New York, NY1.99MShares$1.41 Million0.02% of portfolio
-
Sage Rhino Capital LLC1.7MShares$1.21 Million0.34% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$633,1200.02% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct674KShares$478,6770.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $15M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...